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PreviewsAtg7,p62 doublemutant. If themodel pro-
posed by Bonilla et al. (2013) is correct,
the double mutant should exhibit a less
severe phenotype than the single mutant.
Along these lines, experiments that
determine whether the beneficial function
of autophagy is dependent on adaptive
immunity would also be helpful. These
future experiments not only could reveal
which autophagy functions are dominant
over others, but the reagents that are
generated can be used to compare Mtb
with other pathogens and lead to sub-
stantial insight into autophagy-mediated
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The origin and function of extrathymic Aire-expressing cells (eTACs) is incompletely defined. In this issue of
Immunity, Gardner et al. (2013) show that eTACs are a distinct tolerogenic cell population that functionally
inactivates CD4+ T cells to induce peripheral tolerance.Immunological tolerance is the absence of
a pathologic autoimmune response to
self-antigens. In the case of T cells, central
tolerance occurs during thymic develop-
ment and peripheral tolerance provides a
secondary level of protection against
autoreactive lymphocytes that were not
deleted or inactivated in the thymus. If
one assumes that deletion or inactivation
of self-reactive cells requires the presence
of self-antigen (to distinguish them), then a
paradox of central tolerance is how multi-
ple peripheral antigens aremade available
in the thymus. Just over a decade ago, the
‘‘autoimmune regulator’’ (Aire) was shown
to promote ectopic expression of peri-
pheral tissue-specific antigens (PTAs) in
thymic medullary epithelial cells (MECs),
which impose central tolerance through
negative selection of self-reactive T cells
(Anderson et al., 2002). In humans, lack
of a functional Aire protein results in the
development of a multiorgan autoimmune
disease known as autoimmune poly-endocrinopathy-candidiasis-ectodermal
dystrophy (Nagamine et al., 1997), and
animal studies fromAire/mice recapitu-
late most of this phenotype (Anderson
et al., 2002). In addition to expression on
thymic MECs, Aire is also expressed
extrathymically on eTACs (extrathymic
Aire-expressing cells) located in sec-
ondary lymphoid tissue (Gardner et al.,
2008). Previously, Gardner et al. reported
that eTACs are identified as CD45 stro-
mal cells within the secondary lymphoid
organs, capable of interacting with and
deleting CD8+ naive autoreactive T cells
(Gardner et al., 2008). Importantly, eTACs
expressadistinct anddiversearrayof self-
antigenscompared tomTECs.However, a
number of questions remained about the
identity of eTACs and their potential in
inducing peripheral tolerance in CD4+
T cells. In this issue of Immunity, Gardner
et al. (2013) provide evidence that eTACs
are a bone-marrow-derived antigen-
presenting cell (APC) population withphenotypic characteristics distinct from
dendritic cells (DCs) and stromal cells.
They further demonstrate that eTACs
prevent CD4+ T cell-mediated autoimmu-
nity via functionally inactivating this popu-
lation of cells, providing the first evidence
that Aire-mediated expression of PTAs in
eTACs can be an important mechanism
for CD4+ T cell tolerance (Figure 1).
The term ‘‘antigen-presenting cell’’ or
‘‘professional APC’’ is frequently used to
define cells that express both major histo-
compatibility complex (MHC) class I and
class II molecules under basal conditions
(i.e., in the absence of inflammatory
stimuli). Depending upon context and
other variables, such cells may play roles
in the induction of both productive and
tolerogenic T cell responses. Earlier, by
using Aire-reporter mice, Gardner et al.
had identified eTACs in lymphoid organs
as a type of APC contained with the
CD45 stromal cell population (Gardner
et al., 2008). Now, to further characterizeptember 19, 2013 ª2013 Elsevier Inc. 427
Figure 1. Dual Role of Aire in Central and Peripheral Tolerance
Two different types of AIRE-expressing cells populate the thymus or secondary lymphoid tissue, where
they can induce T cell tolerance to self-antigens. mTECs, which express AIRE, act via deletion of self-reac-
tive thymocytes. eTACS, which express high amounts of MHC II but low amounts of the B7 molecules
CD80 and CD86, can delete self-reactive CD8+ T cells or induce unresponsiveness in CD4+ self-reactive
T cells. Whether this latter state is stable or not remains to be determined.
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eration of eTACs in bone-marrow chimera
mice and found that murine eTACs were
not a stromal lineage but rather derived
from the bone-marrow compartment and
were partially radioresistant. Compared
to CD11c+ DCs or B220+ plasmacytoid
DCs, eTACs expressed high amount of
MHC class II on their surface but very
low levels of CD80 and CD86. Further-
more, low expression of CD45, CD11c,
and CD11b in eTACs distinguished them
from the DC cell lineage. Nevertheless,
eTACs did share some common surface
markers with DCs such as Zbtb46, a
recently described DC marker and the
transcription factor Deaf 1. Importantly
the authors identified a human eTAC
equivalent by immunofluorescent staining
of lymph node sections and showed that
human eTACs localized to the subcap-
sular zone between the T cell paracortex
and B cell follicle. Human eTACs were
uniformly MHCII+, CD45lo, and CD11clo.
These data indicate that eTACs are a
new type of APC with distinct features
from stromal cells and DCs. However,
it’s unclear whether eTACs andDCs share428 Immunity 39, September 19, 2013 ª2013common hematopoietic progenitors, and
further work will be necessary to deter-
mine the origin of eTACs and their
relationship with DCs.
To study how antigen presentation by
eTACs affected CD4+ T cells, Gardner
et al. used the BDC2.5 CD4+ T cell re-
ceptor (TCR) transgenic mouse model
and inserted a BDC mimetope peptide
into the MHC class II molecule-associ-
ated invariant chain under control of the
Aire promoter (AdBDC mice). When
BDC2.5 CD4+ T cells were adoptively
transferred to wild-type (WT) nonobese
diabetic (NOD) severe combined immu-
nodeficiency (SCID) mice, they prolifer-
ated rapidly and caused diabetes. How-
ever, in AdBDC mice, the transferred
BDC2.5 cells proliferated extensively but
ultimately were inactivated and failed to
cause diabetes. There are multiple mech-
anisms by which this type of CD4+ T cell
tolerance might occur, including deletion,
regulation, and induction of ‘‘unrespon-
siveness’’ (often termed anergy). Deletion,
if it occurred, was clearly incomplete
because BDC2.5+ cells were recoverable
from AdBDC mice. To study the issue ofElsevier Inc.regulation, the authors deleted CD25+
regulatory T (Treg) cells from the inoculum
of BDC2.5 T cells prior to adoptive trans-
fer. Nonetheless, they observed that
eTAC stimulation of BDC2.5 cells led to
enrichment of Foxp3+ cells (presumably
Treg cells). Critically, however, deletion
of Foxp3+ cells enabled by the use of
Foxp3-diphtheria toxic receptor trans-
genic mice revealed that prevention of
diabetes did not depend on Foxp3+ cells.
Additionally, BDC2.5 cells transferred into
AdBDC mice cells did not demonstrate
dominant-suppressive function to pre-
vent diabetes when they were secondarily
cotransferred with naive T cells to WT
NOD SCID mice.
Thus the presence of BDC2.5+ cells,
which did not cause diabetes even in the
absence of Treg cells, suggests that unre-
sponsiveness is a major mechanism of
tolerance. Confusingly, different terms
have been coined to describe distinct
states of T cell unresponsiveness. For
example, clonal anergy typically refers to
the inactive state of T lymphocytes gener-
ated in vitro by TCR occupancy in
the absence of CD28 costimulation
(Schwartz, 1996) and when occurring
in vivo is often termed adaptive tolerance,
a characteristic which persists despite re-
petitive antigen stimulation (Chiodetti
et al., 2006). The term exhaustion more
commonly refers to the loss of T cell
effector function following chronic antigen
stimulation, most typically during chronic
viral infections or in malignancy (Wherry,
2011). To characterize the nature of the
unresponsive state induced by eTACs,
Gardner et al. performed a number of
assays. They noted that CD4+ T cells
tolerized by eTACs had high expression
of inhibitory receptors such as PD-1 and
Lag3, as is typical of exhausted T cells
(Wherry, 2011). However, blockade of
the PD-1:PDL1 interaction did not prevent
tolerance induction, suggesting that the
unresponsiveness observed is distinct
from exhaustion. In contrast, several lines
of evidence suggested that the unrespon-
sive state was akin to classical anergy
(adaptive tolerance). eTACs expressed
high amounts of MHC class II with low
expression of the CD28-ligands CD80
and CD86. As well, deliberate activation
of costimulatory signals in the form of
anti-CD28 in vitro or anti-OX-40 in vivo
partially abrogated anergy. This partial
prevention of anergy is itself a bit difficult
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Previewsto interpret, because the CD28 activation
experiments were only done in vitro, and
OX40 exerted in vitro but not in vivo
effects. Finally, the tolerized cells were
found to harbor defects in calcium influx
and mitogen-activated protein kinase
phosphorylation, consistent with obser-
vations described earlier for adaptive
tolerance (Chiodetti et al., 2006).
As with any provocative study, ques-
tions are raised as well as answered.
Recently, TCR-mediated induction of E3
ubiquitin ligases such as Cbl-b, Itch, and
Grail has been suggested to mediate
inductionandmaintenanceofTcell anergy
(Mueller, 2004). It will be worthwhile to
determine whether the strong TCR
signaling and absence of costimulation
provided by eTACs actually lead to the
expression of these genes. Also important
will be determining whether or not the
unresponsiveness induced by eTACs isstable and/or progressive to apoptosis
or, alternatively, might be reversible by
inflammatory or growth-promoting cyto-
kines (Figure 1). Anergy induced by TCR
stimulation in theabsenceof costimulation
might be a metastable event in vivo ulti-
mately leading to cell death (Li et al.,
2001). Whether this occurred in the case
of eTACs could not be determined from
the present study, nor is it clear whether
delivery of CD28 costimulation in vivo will
block tolerance. The answer(s) to these
questions will be important if these find-
ings are to be harnessed into a potentially
new and ‘‘fresh’’ therapeutic approach
for autoimmunity and transplantation.
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Previous studies have highlighted the immune-dampening effects of apoptotic cell uptake by phagocytes.
Ohyagi et al. (2013) expose a unique mechanism of immune regulation during viral infection, which is medi-
ated through phagocytosis of apoptotic red cells by dendritic cells.Ideally, immunostimulatory and immuno-
regulatory factors during viral infection
should be balanced to allow for sufficient
generation of innate and adaptive immu-
nity to facilitate viral clearance, while
limiting uncontrolled immune activation
that can result in tissue damage and/or
death. Apoptotic cells (AC) have long
been recognized to participate in immune
regulation through their effects on phago-
cytic cells, including dendritic cells (DCs).
The induction of tolerogenic DCs by AC
bears important relevance to the fields
of autoimmunity and tumor immunology.In contrast, relatively little has been
described regarding the modulation of
immune responses by ACs throughout
the course of viral infections. In this issue
of Immunity, Ohyagi et al. (2013) describe
a process of imperfect compromise
between antiviral immune responses and
AC-mediated immune regulation. Secre-
tion of interleukin-10 (IL-10) by inflamma-
tory monocyte-derived dendritic cells
(Mo-DCs) as a consequence of hemopha-
gocytosis of apoptotic red blood cells
(RBC) protected mice from lethal inflam-
matory responses following injectionwith Toll-like receptor (TLR) agonists (pri-
marily CpG and poly I:C) or chronic lym-
phocytic choriomeningitis virus (LCMV)
infection. In the case of LCMV infec-
tion, there was elevated and persistent
viremia due to compromised immunity.
In this study, the authors have described
an unusual mechanism of immune regula-
tion during viral infection that provides
new perspectives on big picture ques-
tions regarding the complex interplay
between virus and host.
Ohyagi et al. have now demonstrated
that hemophagocytosis of apoptoticptember 19, 2013 ª2013 Elsevier Inc. 429
